| GlaxoSmithKline AG - Poliorix, Injektionslösung | | 00669 | | 01 | | Poliorix | | Injektionslösung | | J07BF03 | | Poliomyelitis, trivalent, inaktiviert, ganzes Virus | | 28.07.2003 | | |
| | Composition | | virus poliomyelitis typus 1 inactivatus 40 U., virus poliomyelitis typus 2 inactivatus 8 U., virus poliomyelitis typus 3 inactivatus 32 U., medium199, polysorbatum 80, conserv.: formaldehydum 0.01 mg, phenoxyethanolum 2.5 mg, residui: neomycini sulfas max.0.05 ng, polymyxini B sulfas max. 0.01 ng, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml. | | Packungsbestandteile | | Solution injectable | | | | | | | | | BAG: Principe actif | Concentr. |
|---|
| Virus Poliomyelitis Typus 1 Inactivatum (Mahoney) | 40 U | | Virus Poliomyelitis Typus 2 Inactivatum (Mef1) | 8 U | | Virus Poliomyelitis Typus 3 Inactivatum (Saukett) | 32 U |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Formaldehydum | 0.01 mg | conserv. | | Inactivatus | 32 U | | | Medium199 | | | | Neomycine Sulfate | 0.05 ng | residui | | Phénoxyéthanol | 2.5 mg | | | Polymyxine b Sulfate | 0.01 ng | | | Polysorbatum 80 | | | | Virus Poliomyelitis Typus | 3 | |
| |
| Principe actif | Concentr. |
|---|
| Virus Poliomyelitis Typus 1 Inactivatum (Mahoney) | 40 U | | Virus Poliomyelitis Typus 2 Inactivatum (Mef1) | 8 U | | Virus Poliomyelitis Typus 3 Inactivatum (Saukett) | 32 U |
| | BAG: Principe actif | Concentr. |
|---|
| Virus Poliomyelitis Typus 1 Inactivatum (Mahoney) | 40 U | | Virus Poliomyelitis Typus 2 Inactivatum (Mef1) | 8 U | | Virus Poliomyelitis Typus 3 Inactivatum (Saukett) | 32 U |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| Aucune entrée n'a été trouvée. |
|
|
